Company profile NAUT

Nautilus Biotechnology Inc
born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized a...nd predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed. Show More
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology login to provide analysis

Correlation between past revenue and Nautilus Biotechnology login search interest

There is not enough data for Nautilus Biotechnology login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology jobs to provide analysis

Correlation between past revenue and Nautilus Biotechnology jobs search interest

There is not enough data for Nautilus Biotechnology jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 19:51:49.

After 39 days of this quarter the interest is at 11.0. Based on that we can calculate that during remaining 52 days it will total up to 26.0.
Nautilus Biotechnology stock expected interest is significantly lower compared to previous quarter (-43.5%) and same quarter last year (-75.7%).

YearQ1Q2Q3Q4
201930
69
130.0% QoQ
8
-88.4% QoQ
38
375.0% QoQ
2020 72
140.0% YoY 89.5% QoQ
31
-55.1% YoY -56.9% QoQ
54
575.0% YoY 74.2% QoQ
111
192.1% YoY 105.6% QoQ
2021 259
259.7% YoY 133.3% QoQ
106
241.9% YoY -59.1% QoQ
242
348.1% YoY 128.3% QoQ
110
-0.9% YoY -54.5% QoQ
2022 160
-38.2% YoY 45.5% QoQ
97
-8.5% YoY -39.4% QoQ
29
-88.0% YoY -70.1% QoQ
59
-46.4% YoY 103.4% QoQ
2023 107
-33.1% YoY 81.4% QoQ
74
-23.7% YoY -30.8% QoQ
88
203.4% YoY 18.9% QoQ
46
-22.0% YoY -47.7% QoQ
2024 11
-89.7% YoY -76.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Nautilus Biotechnology stock search interestLast update: February 09 2024 19:51:48.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 19:51:51.

The average 5 years interest of Nautilus Biotechnology stock was 6.9 per week.
The last year interest of Nautilus Biotechnology stock compared to the last 5 years has changed by -22.17%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 57.02%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for proteomics platform to provide analysis

Correlation between past revenue and proteomics platform search interest

There is not enough data for proteomics platform to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for proteomics platform to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology Seattle to provide analysis

Correlation between past revenue and Nautilus Biotechnology Seattle search interest

There is not enough data for Nautilus Biotechnology Seattle to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology Seattle to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology headquarters to provide analysis

Correlation between past revenue and Nautilus Biotechnology headquarters search interest

There is not enough data for Nautilus Biotechnology headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology technology to provide analysis

Correlation between past revenue and Nautilus Biotechnology technology search interest

There is not enough data for Nautilus Biotechnology technology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology technology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology instruments to provide analysis

Correlation between past revenue and Nautilus Biotechnology instruments search interest

There is not enough data for Nautilus Biotechnology instruments to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology instruments to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Nautilus Biotechnology software analysis to provide analysis

Correlation between past revenue and Nautilus Biotechnology software analysis search interest

There is not enough data for Nautilus Biotechnology software analysis to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Nautilus Biotechnology software analysis to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for NAUT
Earnings date: 2024-02-28 After close
Company name: Nautilus Biotechnology Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-28T12:00:00Z

GlobeNewswire
Nautilus Biotechnology Reports First Quarter 2026 Financial Results

2026-04-09T12:00:00Z

GlobeNewswire
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

2026-03-24T12:00:00Z

GlobeNewswire
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

2026-03-02T13:00:00Z

GlobeNewswire
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

2026-02-27T15:41:33Z

Analyst Upgrades
Guggenheim Maintains Buy on Nautilus Biotechnology, Raises Price Target to $4

2026-02-26T13:00:00Z

GlobeNewswire
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

2026-02-24T13:00:00Z

GlobeNewswire
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026

2026-02-19T21:05:00Z

GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

2026-02-05T13:00:00Z

GlobeNewswire
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

2026-01-28T13:00:00Z

GlobeNewswire
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease

2026-01-08T13:00:00Z

GlobeNewswire
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

2025-11-03T13:00:00Z

GlobeNewswire
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

2025-10-28T12:00:00Z

GlobeNewswire
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

2025-10-07T12:00:00Z

GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025

2025-09-09T16:42:25-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Nautilus Biotechnology, Inc. (0001808805) (Issuer)